Tag Archives: Research and Innovation

A Further Set-Back for Progress in Dementia Drug Development? (BBC News)

Posted on January 11, 2018 by Dementia and Elderly Care News

Summary Drug company Pfizer is to cease activity in its neuroscience drug discovery programmes, which will impact on ongoing research into drugs for Alzheimer’s Disease and Parkinson’s Disease. Paradoxically the company does promise plans to create a new fund dedicated … Continue reading →

Posted in BBC News, For Researchers (mostly), In the News, International, Management of Condition, Pharmacological Treatments, Quick Insights, Universal Interest | Tagged Big Pharma, Dementia Research, Dementia Research Funding, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Drug Discovery Programmes, Drug Identification, Drug Trials Failure Rate, Drug-Development Pipeline, Global Context, Global Outlook, International Organisations, International Programmes, Neurological Conditions, Neurological Disease, Neurological Disorders, Neuroscience Drug Discovery Programmes (Pfizer), Neuroscience Research, Pfizer, Pfizer Inc., Pharmaceutical Industry, Research and Development, Research and Innovation, Research Commitment, Research Funding | Leave a comment

Research Towards a World Without Dementia: Marking World Alzheimer’s Day / World Alzheimer’s Month 2017 (Alzheimer’s Disease International / Department of Health)

Posted on September 23, 2017 by Dementia and Elderly Care News

Summary Information is available from Alzheimer’s Disease International (ADI) concerning World Alzheimer’s Month (September) and World Alzheimer’s Day 2017, which was on September 21st 2017. The theme for this year’s World Alzheimer’s Month campaign is again “Remember Me”. The UK … Continue reading →

Posted in Charitable Bodies, Commissioning, Department of Health, Diagnosis, In the News, Integrated Care, International, Management of Condition, Mental Health, Models of Dementia Care, National, NHS, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Quick Insights, Standards, UK, Universal Interest | Tagged 70th World Health Assembly Adopted Global Action Plan on Dementia, Ageing Population, Awareness, Awareness Campaigns, Awareness Raising, Carey Mulligan, Carey Mulligan: UK Global Dementia Friends Ambassador, Collaborative Research, Collaborative Working, Community and Voluntary Sector, Dementia Awareness Campaigns, Dementia Awareness Raising, Dementia Friends, Dementia Friends Programme, Dementia Research, Dementia Research Institute (DRI), Dementia-Friendly Communities, Dementia-Friendly Environments, Dementia-Friendly Organisations, Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Drug Discovery Programmes, First G8 Dementia Summit, G8 Dementia Summit, G8 Dementia Summit Declaration, G8 Dementia Summit: Global Action Against Dementia, Global Action Against Dementia, Global Action Plan on Dementia, Global Alzheimer’s and Dementia Action Alliance, Global Alzheimer’s and Dementia Action Alliance (GADAA), Global Context, Global Dementia Friends Ambassadors, Global Leadership, Health Secretary Jeremy Hunt, International Collaborations, International Dementia Research, Leadership for Compassionate Care, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, Partnership Working, Reducing Stigma, Research and Development, Research and Innovation, Research Commitment, Rt Hon Jeremy Hunt MP: Secretary of State for Health, Stigma of Dementia, Stigma-Free Environments, UK Dementia Research Institute, UK Dementia Research Institute (UK DRI), Voluntary Organisations, WHO Global Action Plan on the Public Health Response to Dementia 2017-2025, World Alzheimer's Month 2017 (Remember Me), World Alzheimer’s Day 2017, World Alzheimer’s Month 2017, Yuichiro Miura: Japan’s Dementia Supporters Ambassador | Leave a comment

Funding for Research and Innovation in Health and Social Care (Department of Health / AHSNs / NHS Digital / MRC / UKRI)

Posted on July 17, 2017 by Dementia and Elderly Care News

Summary The government has announced new funding of up to £86 million for UK firms to develop and test new technologies in the NHS. This development is a follow-up to the Accelerated Access Review (AAR). This initiative for more rapid … Continue reading →

Earlier Diagnosis Research: the Deep and Frequent Phenotyping Study (BBC News / GtR)

Posted on June 28, 2017 by Dementia and Elderly Care News

Summary The Deep and Frequent Phenotyping Study aims to discover new ways of diagnosing dementia, ideally decades before the symptoms become apparent in order to give future drug treatments the best chance of working. The Deep and Frequent Phenotyping Study … Continue reading →

Posted in Alzheimer's Society, BBC News, Commissioning, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Mental Health, Models of Dementia Care, National, NIHR, Quick Insights, UK, Universal Interest | Tagged Ageing Population, Alterations in Movement and Walking (“Gait”) Assessments, Alzheimer's Disease: Early Detection by Brain Scan, Alzheimer’s Disease Biomarkers, Amnestic Mild Cognitive Impairment (a-MCI), Amnestic Mild Cognitive Impairment (aMCI), Applications of Big Data, BBC Radio, BBC Radio 4, BBC's World At One Programme, Big Data Analytics, Big Data Funding and Research, Biomarker Assessments in Alzheimer’s Disease, Biomarker Assessments in Alzheimer’s Disease Clinical Trials, Biomarker Assessments in Clinical Trials, Biomarker Development, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Biomarkers Research Programmes, Blood and Urine Biomarkers, Blood-Based Biomarkers, Blood-Based Biomarkers of Pre-Symptomatic Alzheimer’s Disease, Brain Scans, Cambridge Neuropsychological Test Automated Battery (CANTAB), Cerebrospinal Fluid (CSF) Biomarkers, Clinical Assessments, Cognitive Assessments / Screening Tools, Conversion to Dementia From Prodromal Disease, CSF Biomarkers, Deep and Frequent Phenotyping Study, Deep and Frequent Phenotyping Study (DFP), Deep and Frequent Phenotyping; Combinatorial Biomarkers of Dementia, Dementia Research, Dementia Research Funding, Dementias Platform UK, Dementias Platform UK (DPUK), Dementias Platform UK: MRC, DFP Study Team, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, DPUK: Dementias Platform UK, Drug Trials Failure Rate, Early Detection of Alzheimer’s Disease, Early Detection of Preclinical Disease, EEG: Electroencephalography, Effectiveness of Early Detection and Treatment, Electroencephalogram (EEG) Brain Scans, Electroencephalography (EEG), Gait and Cognition, Gait Changes, Gateway to Research (GtR), Global Dementia Research, Global Leadership, Hypothetical Prodromes of Dementia, Imanova, Imperial College London, Join Dementia Research, Join Dementia Research: Clinical Trials Matchmaker Service, Join Dementia Research: Recruitment Onto Dementia Studies, Kings College London, Magnetic Resonance Imaging (MRI) Scan, Magnetoencephalography (MEG), Medical Research Council (MRC), Medical Research Council (UK), National Institute of Health Research (NIHR), Neurobiology of Aging (Journal), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, Newcastle University, Non-Invasive Biomarkers, Ocular Manifestations in Neurodegenerative Diseases, Open Data and Big Data, Ophthalmological Assessments, Participation in Research, Participation in Research Studies, Partnership and Collaboration, Patient and Public Participation, PharmaCog Consortium, Positron Emission Tomography (PET), Pre-Clinical Genotype-Phenotype Predictors of Alzheimer's Disease, Prodromal Alzheimer's Disease, Professor Clare Mackay: Imaging Neuroscience at the University of Oxford, Professor Lynn Rochester: Clinical Ageing Research Unit at Newcastle University, Professor Simon Lovestone: Lead Researcher and Professor of Translational Neuroscience at University of Oxford, Protein-Based Biomarkers in Blood May Deliver Accurate Diagnoses, Proteomic Analysis, Proteomics, Public Participation in Research, Publicly-Funded UK Big Data Research, Research and Development, Research and Innovation, Research Commitment, Research Culture, Research Funding, Retina as Early Biomarker of Neurodegeneration, Retinal Biomarkers, Retinal Changes as Surrogate Biomarker for Alzheimer's Disease, Retinal Ganglion Cells (RGCs), Retinal Manifestations of Alzheimer's Disease, Screening Tools for Amnestic Mild Cognitive Impairment (a-MCI), Surrogate Biomarkers of Neurodegeneration, Translational Research, University College London, University of Cambridge, University of Edinburgh, University of Manchester, University of Oxford, Volunteers, Walking Pattern (Gait), Wearable Devices, Wearables (Technology) | Leave a comment

Innovation for Efficiency, Productivity and Affordability in Healthcare (ILC-UK / EY)

Posted on June 11, 2017 by Dementia and Elderly Care News

Summary A report from the International Longevity Centre covers seven examples of UK-based and international schemes involving innovation. These examples are: Memory First: an integrated dementia service run by a consortium of 162 GPs across 41 practices in Staffordshire. Urban … Continue reading →

Posted in Charitable Bodies, Commissioning, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, International, Management of Condition, Models of Dementia Care, National, Non-Pharmacological Treatments, Patient Care Pathway, Person-Centred Care, Quick Insights, Standards, Statistics, UK, Universal Interest | Tagged Accelerating Innovation, Access to Care, Access to General Practice, Access to GP Services, Adopters and Adoption of Innovation, Affordability, Affordability of Care, Ageing Population, Barriers to Innovation, Belgium, Benefits of Case Management, Care Coordination / Case Management Approaches For People With Dementia Living at Home, Case Management, Closing the NHS Funding Gap, EASYCare, EASYCare Project, Economic Sustainability, Effective Innovation for Affordable Healthcare, Efficiencies and Productivity Gains, Encouraging Innovation, Ernst & Young, EY, Health and Social Care Integration, Home Dialysis, ILC-UK: International Longevity Centre UK, Innovation, Innovation and Improvement, Innovation for an Ageing Population, Integrated Dementia Care, International Longevity Centre UK (ILC-UK), Manchester Royal Infirmary, Memory Assessment Services, Memory Clinics, Memory First, Memory First (Staffordshire), Memory Services, NHS Belongs to the People, NHS Efficiency Challenge, NHS Funding, NHS Funding Gap, Operational Productivity and Performance (Carter Report), Personalised Case Management, Potential NHS Provider Productivity improvements, Productivity, Productivity and Prevention (QIPP) Programme, Productivity in the NHS, Protocol 3 (P3), Redesigning Care Pathways, Redesigning Services, Research and Innovation, Rio de Janeiro, Science and Innovation, Service Redesign (Telehealth), Service Redesign for Productivity, Service Transformation, SOS 2020, Staffordshire, Supporting Economic Growth, Supporting Research and Innovation, Sustainability, Tackling Barriers to Innovation, Tackling Variation, Task Force on E-Health, Transformational Commissioning, Transformational Technologies, Transformative Technology, Transparency, Unwarranted Variations, Urban E-Health Pilot, Variations in Procurement, Variations in Spending, Wasted Resources | Leave a comment

The NHS Mandate: a Revised Mandate from the Government to NHS England, April 2017 to March 2018 (Department of Health)

Posted on March 22, 2017 by Dementia and Elderly Care News

Summary The Department of Health’s updated “NHS Mandate 2017 to 2018” defines long-term NHS objectives and goals up to 2020. The Mandate is based around seven “big picture” objectives: Improving local and national health outcomes, and reduce health inequalities, through … Continue reading →

Posted in Acute Hospitals, Commissioning, Community Care, Department of Health, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Integrated Care, Mental Health, Models of Dementia Care, National, NHS, NHS England, Person-Centred Care, Quick Insights, Standards, UK, Universal Interest | Tagged 2017-18 Financial Directions to NHS England, 2020 Dementia Challenge, Accelerated Access Review, Accelerating Innovation, Ageing Population, Ambitions for the NHS (NHS Mandate), Better Care Fund: Policy Framework, Better Out-of-Hospital Care to Prevent Attendance and Admissions, CCG and STP Performance, Challenge on Dementia 2020, Challenge on Dementia 2020 Implementation Plan, Coordinated Health and Social Care, Core Patient Access Standards, Dementia Diagnosis Rates, Diabetes Prevention Programme, Effectiveness of Post-Diagnosis Dementia Care in Sustaining Independence and Improving Quality of Life, Efficiencies and Productivity Gains, Encouraging Innovation, End-User Experience, Enhancing Quality of Life for People with Long Term Conditions, Excess Treatment Costs Guidance, Financial Constraints, Financial Context, Financial Difficulties, Financial Directions to NHS England, Financial Sustainability in the NHS, Five Year Forward View (NHS England), Freeing the NHS to Innovate, General Practice Forward View (GPFV), Health and Social Care, Health and Social Care Integration, Health and Social Care Integration Fund, Health and Social Care Integration: Overall 2020 Goals, Health Inequalities, Health Inequalities in England, Health Secretary Jeremy Hunt, Healthy Lifestyles, Healthy lives, Helping People Recover, Hospital Productivity, Improving Dementia Diagnosis Rates, Improving Patient Safety, Innovation in the NHS, Integrated Out-of-Hospital Care, Integration of Health and Social Care, Leadership Development and Improvement Board, Leadership Development and Improvement Framework, Learning Disabilities, Local Sustainability and Transformation Plans (STPs), Maternity Experience Challenge Fund, Maternity Transformation Programme, Mental Health and Learning Disabilities, Mental Health Five Year Data Plan, Mental Health Five Year Forward View, Mental Health Five Year Forward View Implementation Plan, Mental Health Workforce Strategy, New Care Models, New Care Models Programme, New Models of Care, NHS 70 (NHS 70th Birthday), NHS 70th Birthday, NHS England’s Budget, NHS England’s Five Year Forward View, NHS Mandate, NHS Mandate 2017 to 2018, NHS Productivity, NHS Reform, NHS Reform in England, NHS Sustainability, NHS: Safest Healthcare System in the World (Ambition), NHS’s 70th Birthday, Out-of-Hospital Care, Out-of-Hospital Services, Parity of Esteem, Patient Experience, Patient Safety, Post-Diagnosis Support, Post-Diagnostic Dementia Support, Post-Diagnostic Support, Premature Death, Premature Mortality, Prevention, Prevention Agenda, Productivity Improvements, Productivity in the NHS, Quality of Life for People With Dementia, Quality of Life for People With Long Term Conditions, Reducing Health Inequalities, Research and Innovation, Rt Hon Jeremy Hunt MP: Secretary of State for Health, Saving Babies’ Lives Care Bundle, Service Transformation, Seven-Day GP Access, Seven-Day NHS Services, Seven-Day Opening, Seven-Day Services in Hospital, Seven-Day Working, Supporting Research and Innovation, Sustainability, Sustainability and Transformation Plans (STPs), Thinking Like a Patient and Acting Like a Taxpayer, UK Strategy for Rare Diseases | Leave a comment

The Reproducibilty Problem / Replication Crisis in Science: a Pervasive Issue in Medicine? (BBC News / Nature / Elife)

Posted on February 26, 2017 by Dementia and Elderly Care News

Summary It has been estimated that between 65% and 90% of researchers typically fail to reproduce fellow scientists’ research results. The Reproducibility Project: Cancer Biology has raised awareness of the prevalence of this problem in biomedical science. The issues are … Continue reading →

Posted in BBC News, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Non-Pharmacological Treatments, Pharmacological Treatments, Quick Insights, Standards, Statistics, Universal Interest | Tagged BBC Radio 4 Today, BBC Radio 4: Today Programme, BBC Science and Environment News, BBC Science News, Belief and Culture, Biomedical Research, Canada, Cancer Research, Cancer Research in the UK, Center for Open Science (Charlottesville USA), Culture and Leadership, Culture Change, Culture of Impact Over Scientific Substance / Rigour (Alleged), Dame Ottoline Leyser: Director of Sainsbury Laboratory at the University of Cambridge, Dementia Research and Drug Development, Elife, Evidence Uncertainties, Learning Culture, Living With Uncertainty, Making Sense of Uncertainty, McGill University in Montreal, Nature, Replicability, Replication, Reproducibility Project: Cancer Biology, Reproducibilty, Reproducibilty Crisis (sic), Research and Innovation, Research Culture, Research Culture Good Practice, Sainsbury Laboratory at the University of Cambridge, Uncertainty, United States, University of Edinburgh, University of Virginia, University of Virginia's Centre for Open Science, USA, Wasted Resources | Leave a comment

Tag Archives: Research and Innovation

A Further Set-Back for Progress in Dementia Drug Development? (BBC News)

Research Towards a World Without Dementia: Marking World Alzheimer’s Day / World Alzheimer’s Month 2017 (Alzheimer’s Disease International / Department of Health)

Earlier Diagnosis Research: the Deep and Frequent Phenotyping Study (BBC News / GtR)

The Reproducibilty Problem / Replication Crisis in Science: a Pervasive Issue in Medicine? (BBC News / Nature / Elife)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites